Paolo Fundaro, Director, 10% Owner at INTERCEPT PHARMACEUTICALS, INC. (ICPT), sold 1,626,888 shares at $50.55 ($77.6M) on 2020-08-14, disclosed to the SEC on 2020-08-17.
Open-market sale of $77.6M ICPT by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.60 | 83,000 | $4.4M | 5.6% |
| 2 | $50.55 | 54,600 | $2.8M | 3.6% |
| 3 | $46.75 | 1,235,512 | $57.8M | 74.4% |
| 4 | $50.15 | 126,888 | $6.4M | 8.2% |
| 5 | $50.15 | 126,888 | $6.4M | 8.2% |
| Total | $47.71 avg | 1,626,888 |
| $77.6M |
| 100% |
| Filing → |
| ICPT | SELL | 2015-07-24 | $166K | — | Filing → |
| ICPT | SELL | 2014-08-12 | $78K | — | Filing → |
| ICPT | SELL | 2014-05-09 | $75K | — | Filing → |